市場調查報告書
商品編碼
965015

羊膜全球市場:增長,趨勢,預測(2020-2025)

Amniotic Membrane Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,羊膜市場預計將以10.5%的複合年增長率增長。這可能是由於事故和外傷案例的數量增加以及人們對羊膜提供的益處有了更多的瞭解。

  • 在角膜手術中,羊膜可促進上皮形成,增強基底上皮細胞粘附,維持上皮表型並調節正常的角膜,結膜和角膜緣成纖維細胞增殖。它具有一些抗菌和生物學特性。這些膜還可以防止細胞凋亡並抑制疤痕,炎症和血管生成。
  • 羊膜的好處,如緩解疼痛的特性,可導致這些組織性產品在眼科和外科傷口中的採用增加。此外,外科手術數量的增加以及幹細胞和再生醫學領域在研發方面的支出增加也是推動整個市場的一些關鍵因素。
  • 根據全球疾病負擔,2017年全球估計有89,910,460燒傷被發現。在這種高燒傷率的驅動下,羊膜的發炎和抗瘢痕形成特性對於減少加劇的發炎和不適感至關重要,從而擴大了整個市場。

本報告調查了羊膜的全球市場,概述了市場,分析了市場增長和障礙,市場機會,酵素,應用,最終用戶和地區以及競爭狀況對市場規模的變化和預測,提供系統信息,例如主要公司的簡介。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場驅動力
    • 事故和傷害數量增加
    • 提高人們對羊膜的益處的認識
    • 增加的幹細胞生物學和再生醫學研究
  • 市場限制要因
    • 缺乏標準化的準則
    • 缺乏熟練的專業人員
  • 波特的五力分析

第5章市場細分

  • 按酵素
    • 冷凍羊膜
    • 脫水羊膜
  • 按應用
    • 眼科
    • 手術傷口
    • 其他
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • Amnio Technology LLC
    • Celularity Inc.
    • Human Regenerative Technologies LLC
    • Katena Products Inc.
    • MiMedx
    • Integra LifeSciences Corporation
    • Skye Biologics Inc.
    • Amniox Medical Inc.

第7章市場機會和趨勢

目錄
Product Code: 69149

The amniotic membrane market is expected to register a CAGR of 10.5% during the forecast period. This can be attributed to the rise in the number of accident and trauma cases and increasing awareness about the benefits offered by the amniotic membrane.

Key Highlights

  • Amniotic membrane has several antimicrobial and biological properties in corneal surgery, as it enhances epithelialization, reinforces adhesion of basal epithelial cells, maintains epithelial phenotype, and modulates the proliferation of normal corneal, conjunctival, and limbal fibroblast. These membranes also prevent apoptosis, as well as inhibit scarring, inflammation, and neovascularization.
  • The advantages of amniotic membranes, like its pain-reducing properties, may lead to the rising adoption of these tissue-based products in ophthalmology and surgical wounds. Moreover, the growing number of surgeries performed and rising expenditure in R&D in the field of stem cells and regenerative medicine are also some of the key factors driving the overall market.
  • As per the Global Burden of Diseases, in 2017, an estimate of 8,99,10,460.00 cases of burn injuries was registered globally. Driven by this high incidence of burn injuries, the inflammatory and anti-scarring properties of the amniotic membrane are pivotal in reducing intensified inflammation and discomfort and, thus, boost the overall market.

Key Market Trends

The Opthalmology Segment is Estimated to Witness a Healthy Growth in the Future.

The ophthalmology segment is estimated to witness a healthy growth in the future, which can be majorly attributed to the widespread use of these tissue-based products in ophthalmic surgeries due to their fast recovery properties, like reducing inflammation and promoting healing. The increasing use of the amniotic membrane in ophthalmic plastic and reconstructive surgeries to reduce scarring and diagnose quickly is propelling the segment growth. Moreover, the rising number of patients opting for surgeries, for the aesthetic appeal, is also boosting the amniotic membrane market. For instance, as per the American Society of Plastic Surgeons, in 2018, 17.7 million cosmetic procedures were carried out. The increasing demand for products in cosmetic surgeries and reconstructive surgeries is driving the overall market. Compared to xenografts and allografts, amniotic membranes are cheaper, which also promotes the segment growth.

In addition, the growing population of glaucoma patients globally fuels the amniotic membrane market, as these tissue-based products are used for the treatment for ocular surface diseases and in glaucoma for the repair of leaking glaucoma filtering blebs.

North America is Expected to Hold a Significant Share in the Market during the Forecast Period

North America is expected to hold a significant market share due to the increasing aging population, adoption of advanced technologies, growing awareness among the population about alternatives technologies, increasing healthcare expenditure, and the presence of well-established healthcare infrastructure. The wide use of amniotic membranes is for eye surface disorders, leading to the adoption of these products in ophthalmic surgeries. Thus, the increasing number of ophthalmic surgeries performed in the United States, due to the geriatric population, is fueling the growth of the overall market to a large extent.

Competitive Landscape

The amniotic membrane market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies currently dominating the market include Amnio Technology LLC, Celularity Inc., Human Regenerative Technologies LLC, Katena Products Inc., MiMedx, Integra LifeSciences Corporation, Skye Biologics Inc., and Amniox Medical Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Number of Accident and Trauma Cases
    • 4.2.2 Increasing Awareness about the Benefits Offered by Amniotic Membrane
    • 4.2.3 Rising Research on Stem Cell Biology and Regenerative Medicine
  • 4.3 Market Restraints
    • 4.3.1 Lack of Standardized Guidelines
    • 4.3.2 Lack of Skilled Professionals
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Enzyme
    • 5.1.1 Cryopreserved Amniotic Membrane
    • 5.1.2 Dehydrated Amniotic Membrane
  • 5.2 By Application
    • 5.2.1 Ophthalmology
    • 5.2.2 Surgical Wounds
    • 5.2.3 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amnio Technology LLC
    • 6.1.2 Celularity Inc.
    • 6.1.3 Human Regenerative Technologies LLC
    • 6.1.4 Katena Products Inc.
    • 6.1.5 MiMedx
    • 6.1.6 Integra LifeSciences Corporation
    • 6.1.7 Skye Biologics Inc.
    • 6.1.8 Amniox Medical Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS